Expo News Today — July 20, 2026
No one talks about FAANG anymore. Now, it’s time to retire Magnificent Seven as well, Citigroup argues and more — today's expo signal.
Global markets are navigating a complex landscape as geopolitical tensions and corporate developments influence investor sentiment. The ongoing conflict in the Middle East has taken a turn for the worse, with Iran vowing not to allow any oil or gas to transit the Strait of Hormuz, leading to a rise in Brent crude prices to $90. This escalation has also resulted in an increase in the US death toll, adding to concerns about the potential for a broader conflict.
Against this backdrop, the focus is also on the performance of major tech stocks, often referred to as the 'Magnificent Seven'. Citigroup has argued that it's time to retire this label, suggesting that the narrative around these stocks may be losing steam. Meanwhile, some analysts are questioning whether these stocks can single-handedly prop up a stock market that might be facing challenges. In other corporate news, Samsung Biologics has announced a significant acquisition, agreeing to buy Switzerland's PolyPeptide Group in an $1.8 billion all-cash deal. These developments are set to influence market dynamics in the day ahead.
Today's signal:
• No one talks about FAANG anymore. Now, it’s time to retire Magnificent Seven as well, Citigroup argues (marketwatch.com)
• Brent crude breaches $90 as Iran vows not ‘a single drop’ of oil or gas will transit Hormuz (cnbc.com)
• Samsung Biologics to acquire Switzerland's PolyPeptide Group in $1.8 billion all-cash deal (cnbc.com)
• U.S. death toll rises again as Iran war escalates over the weekend (cnbc.com)
• Can the ‘Magnificent Seven’ save a stock market that might be doomed without them? (marketwatch.com)